Market Share of Global Anti-tuberculosis Therapeutics Industry
The anti-tuberculosis therapeutics market is highly consolidated, with very few companies holding a substantial market share. With the rising focus of the healthcare sector on the development of novel drugs and the growing investment in research and development, more small to mid-sized companies are estimated to enter the market in the coming future. Some of the companies in the market are Lupin, Macleods Pharmaceuticals Ltd, Otsuka Pharmaceutical Co. Ltd, and Johnson and Johnson holds the largest market share.
Anti-tuberculosis Therapeutics Market Leaders
Macleods Pharmaceuticals Ltd
Otsuka Pharmaceutical Co. Ltd
Johnson and Johnson
Sequella, Inc.
Lupin Limited
*Disclaimer: Major Players sorted in no particular order
